Evaluation of SARS-CoV-2 infection risks after primary vaccination with BNT162b2, BBIBP-CorV, or ChAdOx1-nCOV-19 and after homologous and heterologous booster vaccinations with the...

por Djorwé, Soulandi, Bousfiha, Amale, Nzoyikorera, Néhémie, Nyandwi, Joseph, Kawthar, Bellamine, Malki, Abderrahim
Publicado 2023

Epidemiology, clinical characteristics and risk factors of coronavirus disease 2019 (COVID-19) in Casablanca

por Djorwé, Soulandi, Bousfiha, Amale, Nzoyikorera, Néhémie, Nkurunziza, Victor, Ait Mouss, Khadija, Kawthar, Bellamine, Malki, Abderrahim
Publicado 2023